Mannitol
Approved · EMAAlso known as Bronchitol, D-(-)-Mannitol, D-Mannitol, Manna Sugar+10 more
Bronchitol, D-(-)-Mannitol, D-Mannitol, Manna Sugar, Mannitol, Injectable, Mannitol-Sorbitol, Osmitrol, Resectisol, Manitol, Mannit, Mannite, (2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexaol, (2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol, Mannitolum.
Recent clinical, regulatory, research and industry developments relating to this drug.
Budesonide as a Treatment for Low-grade Duodenal Inflammation in Functional Dyspepsia
Adding Dexmedetomidine to Mannitol to Attenuate the Increase of Intracranial Pressure
Propofol Level at TCI During Mannitol
Memantine as an Additive Therapy in Patients With Traumatic Brain Injury
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Regulatory timeline
The complete regulatory record, grouped by authority — approvals, safety advisories and label changes. Each authority shows its most recent events; expand one to read its full history.
Indication: Bronchitol is indicated for the treatment of cystic fibrosis (CF) in adults aged 18 years and above as an add-on therapy to best standard of care.
Evidence ↗Contains information from the European Medicines Agency (European Medicines Agency), © EMA, reused under CC BY 4.0.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes2
Journals, researchers & institutions
- Medicine1
- The Plant cell1
- Abe H1
- Abe I1
- Abe M1
- Fujita Y1
- Ito T1
- Kobayashi K1
- Koga M1
- Kudo T1
- Clinical Research Support Center1
- Fukuoka University1
- Fukuoka University Chikushi Hospital1
- Japan International Research Center for Agricultural Sciences1
- Nagasaki Prefecture Iki Hospital1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials
- Regulatory event sources are credited in the Regulatory Timeline above.